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ABSTRACT 
Objective: The present study was undertaken to screen the anti-inflammatory activity of Helicia nilagirica Bedd., an ethnomedicinal plant of 
Mizoram, India.  
Methods: In this study, inflammation was induced by cotton pellet granuloma model (Sub-acute) using the method adopted by D’Arcy (1960). The 
anti-inflammatory effect of two doses of methanolic extract of Helicia nilagirica Bedd. was tested and diclofenac was used as a standard drug. The 
statistical analysis was carried out by One-way Analysis of Variance (ANOVA) followed by Dunnett’s multiple comparison tests using GraphPad In 
Stat 3.0 software. 
Results: This in vivo anti-inflammatory study shows that the plant extract at two different doses (250 mg/kg and 500 mg/kg) possess significant 
anti-inflammatory activity (p<0.01). The standard drug diclofenac (10 mg/kg) produces maximum activity by inhibiting the wet weight and dry 
weight of the cotton pellet, 37.45 % and 43.70 % respectively. Two different doses of the plant extract show significant reduction of wet weight and 
dry weight of cotton pellet at 15.30% and 17.67% respectively for 250 mg/kg and 21.98% and 23.35% for 500 mg/kg respectively. 
Conclusion: The result of the study shows that the methanolic bark extract of Helicia nilagirica Bedd. possess anti-inflammatory activity. 
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Inflammation is defined as the local response of living tissues to 
injury due to any agent. It is a body defence reaction in order to 
eliminate or limit the spread of injurious agent, followed by removal 
of the necrosed cells and tissues. Inflammation produces pain 
mediators like bradykinin, histamine, serotonin, prostaglandin, 
etc.[1]. Even though modern drugs are effective in the management 
of inflammation and associated conditions, but their use is often 
limited because of side effects [2]. 
In recent years, there is growing realization that apart from being 
safer, economical and easily available, herbs, phytochemicals and 
herbal products can influence the course of inflammatory diseases 
and may provide an amalgamation of nutritional substances, which 
help in restoring and maintaining wear and tear of tissues. 
Therefore, it would be rational to evaluate scientifically traditional 
medicines used for their potential use in inflammatory diseases [3]. 
The studies of the traditional system of medicines have resulted in 
the development of valuable compounds. Helicia nilagirica Bedd. is 
one of the most commonly used traditional medicine by the people 
of Mizoram. It is a medium sized tree belonging to the family 
Proteaceae. It is commonly known as Pasaltakaza in Mizoram, North 
East India. Traditionally, a decoction prepared by boiling the leaves 
or bark is used for various stomach ailments including peptic ulcers 
and indigestion. It is also used in scabies and other skin diseases [4]. 
Two compounds were isolated from the leaves of Helicia nilagirica. 
Compound 1 was elucidated as 1-O-3-D-glucopyranosyl-(2S, 3S, 4R, 
8Z)-2-[(2'R)-2'-hydroxylignocenoyl-amino]-8-octadecene-1, 3, 4-
triol. Compound 2 was an analogue of compound 1 [5]. Five 
compounds were isolated from the dichloromethane and n-butanol 
extracts of the seeds, identified as p-hydroxybenzaldehyde, p-
hydroxybenzoic acid, gallic acid, helicide, 4-formylpymyl-O-beta-D-
glucopyranoside [6]. There are very few studies reported on the plant 
Helicia nilagirica Bedd., the aim of this study is to evaluate its anti-
inflammatory potential using cotton pellet-induced granuloma in rats. 
Authentication of the plant was done at Botanical Survey of India, 
Kolkata (Voucher No. of the specimen: CHN/46/2013/Tech. II). The 
specimen was deposited at Regional Institute of Paramedical and 
Nursing Sciences, Aizawl. The powdered air-dried bark of Helicia 
nilagirica was extracted successively with petroleum ether and 
methanol using a Soxhlet apparatus. The methanolic extract was 
evaporated under vacuum in a rotary evaporator and used for the 
experiment. 
Male Wistar rats (150-200 g) used in the study was obtained from 
the Animal House of Department of Pharmacy, Regional Institute of 
Paramedical and Nursing Sciences, Mizoram, India. They were 
housed in environmentally controlled conditions with free access to 
water and standard diet. The experimental protocols were approved 
by Institutional Animal Ethics Committee of Department of 
Pharmaceutical Sciences, Dibrugarh University (Approval No: 
IAEC/DU/25 dtd. 21.11.12). The standard drug diclofenac was 
obtained from Novartis. The solvent for extraction, petroleum ether, 
and methanol was purchased from Sigma-Aldrich. 
Acute oral toxicity was performed as per OECD Guideline 423. Two 
groups of animals were used for the study. Group I served as control 
and received distilled water. Group II received single oral dose of 
Helicia nilagirica (2000 mg/kg). The animals were observed for 
gross behavioural, neurological, autonomic and toxic effects at short 
intervals of time for 24 h and then daily for 14 d for any sign of 
delayed toxicity (OECD, 2001).  
In this study, inflammation was induced by cotton pellet granuloma 
model (Sub-acute) using the method adopted by D’Arcy (1960). 
Under light ether anesthesia by using blunted forceps, a 
subcutaneous tunnel was made and sterilized cotton pellets (10±0.5 
mg) were implanted in the axilla and groin region of the rat. After 
recovering from anaesthesia, the animals were treated orally with a 
standard drug, vehicle control (saline 10 ml/kg), standard drug and 
test drug were administered for seven consecutive days. On the 
eighth day, the animals were sacrificed by excessive anaesthesia and 
the cotton pellets were removed surgically. Pellets were separated 
from extraneous tissue and weighed immediately for wet weight and 
then dried at 60 °C until the weight become constant [7]. The 
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percentage inhibition of the wet weight and dry weight of the 
granuloma were calculated and compared. 
The percent inhibition increase in the weight of the cotton pellets 
was calculated by:  
% Inhibition = [Wc– Wt/Wc] × 100  
Where, 𝑊𝑊𝑊𝑊 is granulation weight in treated groups 
𝑊𝑊𝑊𝑊 is granulation weight in control group 
The statistical analysis was carried out by One-way Analysis of 
Variance (ANOVA) followed by Dunnett’s multiple comparison tests 
using GraphPad Instat 3.0 software; p<0.01 was taken to be 
statistically significant. The results are expressed as mean±SEM for 
six animals in each group. 
The results (table 1) shows a marked protection in granuloma by 
Helicia nilagirica Bedd., which markedly reduced the dry weight 
and the wet weight of the cotton pellet at a dose of 250 mg/kg and 
500 mg/kg when compared to control. The standard drug 
diclofenac produces maximum activity by inhibiting the wet 
weight and dry weight of the cotton pellet, 37.45 % and 43.70 % 
respectively. Two different doses of the plant extract show 
significant reduction of wet weight and dry weight of cotton pellet 
at 15.30% and 17.67% respectively for 250 mg/kg and 21.98% 
and 23.35% respectively for 500 mg/kg. 
 
Table 1: Shows the percentage inhibition in the dry weight and wet weight of cotton pellet in treated groups when compared with control 
group 
Group Mean wet weight of cotton 
(mg) 
% Inhibition in wet 
weight 
Mean dry weight of cotton 
(mg) 
% Inhibition in dry 
weight 
Vehicle control (10 
ml/kg) 
119.65±2.83 - 33.47±0.91 - 
H. nilagirica  
(250 mg/kg)  
101.30±3.20** 15.30 27.58±1.0** 17.67 
H. nilagirica  
(500 mg/kg)  
93.33±2.12** 21.98 25.61±0.63** 23.35 
 Diclofenac (10 mg/kg)  74.80±2.96** 37.45 18.0±0.51** 43.70 
Values are expressed as mean±SEM (n=6), **p ˂ 0.01 when compared with control group 
 
It was observed that the extract at dose 250 mg/kg and 500 mg/kg 
produced a significant anti-inflammatory activity by reducing the 
dry weight and wet weight granuloma but lower than the standard 
drug diclofenac. The cotton pellet-induced granuloma is widely used 
to assess the transudative and proliferative components of chronic 
inflammation [8]. The weight of the wet cotton pellets correlates 
with transude material and the weight of dry pellet correlates with 
the amount of granulomatous tissue. Three phases of the 
inflammatory response to a subcutaneously implanted cotton pellet 
in rats have been described. A transudative phase that occurs during 
first 3 h, an exudative phase occurring between 3-72 h after 
implanting the pellet and proliferative phase measured as the 
increase in dry weight of granuloma that occurs between 3 and 6 d 
after implantation [9]. The suppression of proliferative phase of sub-
acute inflammation could result in a decrease in weight of 
granuloma formation [10]. It is well-known fact that diclofenac 
sodium act by inhibiting the prostaglandins synthesis at the late 
phases of inflammation. This effect may be due to the cellular 
migration to injured sites and accumulation of collagen, an 
important mucopolysaccharide [11]. Decreasing granuloma tissue, 
prevention of occurring of the collagen fiber and suppression of 
mucopolysaccharides are indicators of the antiproliferative effect of 
NSAIDs [3]. 
CONCLUSION 
The present study demonstrated that the methanolic bark extract of 
Helicia nilagirica Bedd. has shown significant anti-inflammatory 
action in the sub-acute experimental model, comparable to 
diclofenac. Further studies may be directed to confirm its anti-
inflammatory activity by using other models of anti-inflammatory 
studies and isolation of the actual bioactive ingredients that are 
responsible for the anti-inflammatory activity. 
CONFLICT OF INTERESTS 
Declared none 
REFERENCES 
1. Rang HP, Dale MM, Ritter JM, Flower RJ, Henderson G. 
Pharmacology. 7th ed. Philadelphia: Churchill Livingstone; 
2012.  
2. Lipsky P. The clinical potential of COX-2 specific inhibitors. Am 
J Med 1999;106:51S-7. 
3. Verma S, Ojha S, Raish M. Anti-inflammatory activity of 
Aconitum heterophyllum on cotton pellet-induced granuloma in 
rats. J Med Plants Res 2010;4:1566-9. 
4. Sawmliana M. The book of Mizoram Plants. 1st ed. Aizawl: Lois 
Bet; 2003. 
5. Wu T, Kong DY, Li HT. Structure identification of two new 
cerebrosides from Helicia nilagirica Bedd. Yaoxue Xuebao 
2004;39:525-7. 
6. Liu GY, Cheng S, Zhang YM, Xu JM, Lin RC. Study on chemical 
constituents in seeds of Helicia nilagirica (II). 
Zhongguo Zhongyao Zazhi 2005;30:830-2. 
7. Kaneria MS, Naik SR, Kohli RK. The anti-inflammatory, 
antiarthritic and analgesic activity of a herbal formulation 
(DRF/AY/4012). Indian J Exp Biol 2007;45:278-85.  
8. Winter CA, Porter CC. Effect of alterations in the side chain 
upon anti-inflammatory and liver glycogen activities of 
hydrocortisone esters. J Am Pharm Assoc 1957;46:515-9. 
9. Swingle KF, Shideman FE. Phases of the inflammatory response 
to subcutaneous implantation of a cotton pellet and their 
modification by certain anti-inflammatory agents. J Pharmacol 
Exp Ther 1972;185:226-34. 
10. Kavimani S, Vetrichelvan T, Ilango R, Jaykar B. Anti-
inflammatory activity of volatile oil of Toddalia asiatica. Indian 
J Pharm Sci 1996;58:67-70. 
11. Smith WL, De Witt DL. Biochemistry of prostaglandins 
endoperoxide H synthase-1 and synthase-2 and their 
differential susceptibility to NSAIDs. Semin Nephrol 
1995;15:179-94.
 
